Loading...
Development and Characterization of a Semi-Solid Dosage Form of Meglumine Antimoniate for Topical Treatment of Cutaneous Leishmaniasis
Cutaneous leishmaniasis (CL) is treated with painful intralesional injections of meglumine antimoniate (MA). With the aim of developing an alternative topical treatment for CL, a gel-based formulation with 30% MA was prepared and its physicochemical properties, stability and rheological behavior wer...
Na minha lista:
| Udgivet i: | Pharmaceutics |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6920791/ https://ncbi.nlm.nih.gov/pubmed/31731660 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics11110613 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|